Caro J et al 1997 The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. British Medical Journal 315:1577-1582.
Hooper L et al 2001 Dietary fat intake and prevention of cardiovascular disease: systematic review. British Medical Journal 322: 757-763 Jonsson B 2001 Economics of drug treatment: for which patients is it cost-effective to lower cholesterol? Lancet 358:1251 Knopp R H1999 Drug treatment of lipid disorders.
New England Journal of Medicine 341: 498-511 Mansell P, Reckless J P D 1991 Garlic. British Medical
Journal 303: 379 Oliver M F 2000 Cholesterol and strokes. British
Medical Journal 320: 459-460 Primatesta P, Poulter N 2000 Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional study. British Medical Journal 321:1322-3125 Sacks F M, Pfeffer M A, Moye L A et al 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine 335: 1001-1009
White H D et al 2000 Pravastatin therapy and the risk of stroke. New England Journal of Medicine 343: 317-326
Was this article helpful?